Source link : https://www.newshealth.biz/health-news/glucagon-blocker-and-sglt2-inhibitor-winning-combo-in-t1d/
TOPLINE: In patients with type 1 diabetes (T1D), sodium-glucose cotransporter 2 (SGLT2) inhibitors plus glucagon receptor antagonists (GRAs) may improve glycemic control, reduce insulin use, and mitigate ketogenesis risk compared with SGLT2 inhibitors alone. METHODOLOGY: SGLT2 inhibitors are known to be effective in treating diabetes but can increase fasting glucagon levels, which reduces the drugs’ […]
Author : News Health
Publish date : 2024-06-20 12:57:23
Copyright for syndicated content belongs to the linked Source.
Categories